author-photo

Ira Oliff

7

Papers

2179

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

2019 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (85)
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

2019 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (93)
RXÂ 3117: Activity of an oral antimetabolite nucleoside in subjects with pancreatic cancerâ€“Preliminary results of stage II of the phase Ia/IIb study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (282)
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (96)
Abstract P6-10-01: A randomized phase 2 study of the antibody-drug conjugate CDX-011 in advanced GPNMB-overexpressing breast cancer: The EMERGE study

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (16)
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1606)